Workup for Recurrent Kidney Stones
All patients with recurrent kidney stones (≥1 prior stone episode) require stone analysis if available, basic metabolic blood work (serum calcium, phosphate, uric acid, creatinine), urinalysis with culture, and two 24-hour urine collections obtained at least 6 weeks after a stone episode to measure calcium, phosphate, citrate, oxalate, uric acid, magnesium, sodium, and creatinine. 1, 2
Initial Diagnostic Evaluation
Stone Analysis
- Stone composition analysis should be performed for all first-time stone formers using polarization microscopy, as approximately 80% of stones are calcium-based (oxalate or phosphate), while others consist of struvite, uric acid, or cystine. 3, 4
- Stone type determines specific treatment approaches and guides metabolic workup priorities. 2
Blood Chemistry Panel
- Measure serum calcium, phosphate, uric acid, creatinine, and consider 1,25(OH)2D3 levels to identify systemic metabolic abnormalities such as hyperparathyroidism, sarcoidosis, or renal tubular acidosis. 4, 5
- Include ionized calcium, sodium, potassium, blood cell count, and C-reactive protein if intervention is planned. 6
Urinalysis and Culture
- Perform dipstick urinalysis and urine culture to detect infection, hematuria, and crystalluria. 6, 7
- Microscopic examination under polarized light helps identify crystal types. 8
24-Hour Urine Collections (Critical Component)
- Obtain TWO separate 24-hour urine collections at least 6 weeks after the acute stone episode while patients follow their usual diet. 1, 2, 4
- Measure urine volume, pH, and excretion of calcium, phosphorus, magnesium, uric acid, citrate, sodium, oxalate, and creatinine. 2, 4
- Key abnormalities to identify include:
Imaging Assessment
Initial Imaging
- Ultrasound is the primary diagnostic tool for initial evaluation and should not delay emergency care. 6
- Ultrasound has 45% sensitivity for ureteral stones and 88% specificity for renal stones. 6
Definitive Imaging
- Non-contrast CT is the gold standard for assessing stone location, size, burden, density, and anatomy, with 93.1% sensitivity and 96.6% specificity. 6, 7
- Low-dose CT protocols reduce radiation exposure while maintaining diagnostic accuracy. 6
- KUB radiography (44-77% sensitivity) helps differentiate radiopaque from radiolucent stones and aids in follow-up. 6
Follow-Up Imaging Strategy
- Obtain a single 24-hour urine specimen within 6 months of initiating treatment to assess response to dietary and/or medical therapy. 2
- Follow-up imaging should be performed within 14 days during conservative management to monitor stone position and assess for hydronephrosis. 7
- For postoperative surveillance, ultrasound is preferred initially, with CT reserved for persistent hydronephrosis or clinical concerns. 10
Risk Stratification
High-Risk Features Requiring Intensive Workup
- Patients with solitary kidney, recurrent infections, large stone burden (>2 cm), bilateral stones, anatomic abnormalities (horseshoe kidney, calyceal diverticula), or family history of stones require comprehensive metabolic evaluation. 2, 6, 11
- Stone formers with systemic diseases (hyperparathyroidism, inflammatory bowel disease, chronic diarrhea) need targeted additional testing. 5, 8
Stone Type-Specific Considerations
- Calcium oxalate stones (most common): Focus on hypercalciuria, hyperoxaluria, hypocitraturia, and hyperuricosuria. 3, 4
- Uric acid stones: Measure urinary pH (typically <5.5) and uric acid excretion. 2
- Struvite stones: Identify urease-producing organisms through urine culture. 2, 11
- Cystine stones: Measure 24-hour urinary cystine excretion (>250 mg/24h diagnostic). 2
Common Pitfalls to Avoid
- Do not obtain 24-hour urine collections during or immediately after an acute stone episode, as results will be unreliable; wait at least 6 weeks. 1, 2
- Do not restrict dietary calcium, as this may worsen oxaluria and increase osteoporosis risk; maintain intake at 600-800 mg/day. 4, 9
- Distinguish stone passage from new stone formation—passing a pre-existing stone after dietary changes does not indicate treatment failure. 1
- Do not rely solely on serum uric acid levels for allopurinol therapy decisions; hyperuricemia is not required, but hyperuricosuria (>800 mg/24h) with normocalciuria is the indication. 2, 9
- Avoid overuse of CT scans for routine follow-up; reserve for specific clinical indications to minimize radiation exposure. 10, 12
Metabolic Evaluation Timing
- Basic metabolic workup (stone analysis, blood chemistry, urinalysis) should be performed for ALL stone formers. 1, 6, 7
- Comprehensive metabolic evaluation with 24-hour urine collections is mandatory for recurrent stone formers (≥2 episodes) and high-risk first-time formers. 1, 2, 7
- Reassess with repeat 24-hour urine collection 6 months after initiating preventive therapy to verify biochemical response. 2